• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Glaukos Corporation

    < Previous 1 2 Next >
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Third Quarter 2024 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Second Quarter 2024 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces First Quarter 2024 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces the Release of its 2023 Sustainability Report
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Participation in Stifel Healthcare Conference
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Third Quarter 2023 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Participation in Wells Fargo Healthcare Conference
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Second Quarter 2023 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc.
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Achieves Pipeline Milestone with Enrollment Completion in Phase 3 Confirmatory Trial for Epioxa (Epi-on)
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    Glaukos Announces Participation in the William Blair Growth Stock Conference
    From Glaukos Corporation
    Via Business Wire
    Tickers GKOS
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.